Your browser doesn't support javascript.
loading
Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.
Deribe, Yonathan Lissanu; Sun, Yuting; Terranova, Christopher; Khan, Fatima; Martinez-Ledesma, Juan; Gay, Jason; Gao, Guang; Mullinax, Robert A; Khor, Tin; Feng, Ningping; Lin, Yu-Hsi; Wu, Chia-Chin; Reyes, Claudia; Peng, Qian; Robinson, Frederick; Inoue, Akira; Kochat, Veena; Liu, Chang-Gong; Asara, John M; Moran, Cesar; Muller, Florian; Wang, Jing; Fang, Bingliang; Papadimitrakopoulou, Vali; Wistuba, Ignacio I; Rai, Kunal; Marszalek, Joseph; Futreal, P Andrew.
Affiliation
  • Deribe YL; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ylissanu@mdanderson.org.
  • Sun Y; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Terranova C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Khan F; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Martinez-Ledesma J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gay J; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gao G; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mullinax RA; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Khor T; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Feng N; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lin YH; Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wu CC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Reyes C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Peng Q; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Robinson F; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Inoue A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kochat V; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Liu CG; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Asara JM; Division of Signal Transduction, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
  • Moran C; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Muller F; Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang J; Department of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Fang B; Department of Thoracic, Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Papadimitrakopoulou V; Department of Thoracic, Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rai K; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Marszalek J; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Afutreal@mdanderson.org.
Nat Med ; 24(10): 1627, 2018 Oct.
Article in En | MEDLINE | ID: mdl-30104769
ABSTRACT
In the version of this article originally published, information regarding several funding sources was omitted from the Acknowledgements section. The following sentences should have been included "This work was supported by the generous philanthropic contributions to The University of Texas MD Anderson Lung Cancer Moon Shots Program, the UT Lung SPORE 5 P50 CA07090, and the MD Anderson Cancer Center Support Grant P30CA01667. V.P is supported by R01CA155196-01A1 from the National Cancer Institute." Also, reference 18 was incorrect. The original reference was Kim, E. S. et al. The BATTLE trial personalizing therapy for lung cancer. Cancer Discov. 1, 44-53 (2011). It should have been Papadimitrakopoulou, V. et al. The BATTLE-2 study a biomarker-integrated targeted therapy study in previously treated patients with advanced non-small-cell lung cancer. J Clin. Oncol. 34, 3638-3647 (2016). The errors have been corrected in the HTML and PDF versions of this article.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2018 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2018 Type: Article Affiliation country: United States